CN102302719B - Medicament for treating tumor - Google Patents

Medicament for treating tumor Download PDF

Info

Publication number
CN102302719B
CN102302719B CN2011102519461A CN201110251946A CN102302719B CN 102302719 B CN102302719 B CN 102302719B CN 2011102519461 A CN2011102519461 A CN 2011102519461A CN 201110251946 A CN201110251946 A CN 201110251946A CN 102302719 B CN102302719 B CN 102302719B
Authority
CN
China
Prior art keywords
medicament
tumor
prepared
treating tumor
curative effects
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2011102519461A
Other languages
Chinese (zh)
Other versions
CN102302719A (en
Inventor
刘岑
Original Assignee
刘岑
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 刘岑 filed Critical 刘岑
Priority to CN2011102519461A priority Critical patent/CN102302719B/en
Publication of CN102302719A publication Critical patent/CN102302719A/en
Application granted granted Critical
Publication of CN102302719B publication Critical patent/CN102302719B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention relates to a medicament for treating tumor. The medicament is prepared from the following Chinese herbal medicines: common lophatherum herb, Paris polyphylla, largehead atractylodes, atractylodes lancea, pale butterflybush flower, rhubarb, platycodon grandiflorum, dwarf lilyturf tuber, angelica sinensis, scirpus fluviatilis, Chinese magnoliavine fruit and barbed skullcap herb. The medicament is prepared from pure Chinese medicines, keeps the characteristics of small toxicity and good curative effects of natural medicaments, is exact in curative effects, and can effectively treat tumor.

Description

A kind of medicament of treating tumor
Technical field
The present invention relates to field of medicaments, specifically, relate to a kind of medicament of treating tumor.
Background technology
Tumor (Tumor) be body under various carcinogenic factor effects, some cells of local organization lose the normal regulation to its growth on gene level, cause its clonal abnormality hypertrophy and the neoplasm that forms.It is generally acknowledged that tumor cell is a monoclonicity, promptly all oncocytes in tumor all are offsprings of the cell of a sudden change.Generally tumor is divided into optimum and pernicious two big types.All malignant tumor are generically and collectively referred to as cancer (cancer).
Many clinically at present employing chemicalses are treated, but often the injury for the patient is bigger for chemotherapeutics.
Summary of the invention
The purpose of this invention is to provide a kind of medicament of treating tumor.
In order to realize the object of the invention, the present invention provides a kind of medicament of treating tumor, and it is processed by following bulk drugs by weight:
Preferably, it is processed by following bulk drugs by weight:
Preferably, medicament of the present invention is tablet, dispersible tablet, decoction or capsule.
Medicament of the present invention is prepared with pure Chinese medicine, keeps little, the eutherapeutic characteristic of natural drug toxicity, and curative effect is clear and definite, can treat tumor effectively.
The specific embodiment
Below description through the specific embodiment the present invention is described further; But this is not to be limitation of the present invention; Those skilled in the art are according to basic thought of the present invention; Can make various modifications or improvement, but only otherwise break away from basic thought of the present invention, all within scope of the present invention.
The preparation of embodiment 1 decoction of the present invention
Get Herba Lophatheri 100 gram, Rhizoma Paridis 100 grams, the Rhizoma Atractylodis Macrocephalae 30 grams, Rhizoma Atractylodis 30 grams, Flos Buddlejae 100 grams, Radix Et Rhizoma Rhei 50 grams, Radix Platycodonis 50 grams, Radix Ophiopogonis 100 gram, Radix Angelicae Sinensis 50 grams, triangular 50 grams, Fructus Schisandrae Chinensis 100 grams, Herba Scutellariae Barbatae 100 grams; Place 800 ml waters; 90 ℃ of following reflux 3 hours; Filter, obtain filtering residue and filtrating.Said filtrating is concentrated into 300 milliliters, promptly gets.
Experimental example
Physical data
50 routine patients all confirm through B ultrasonic, CT or MRI imaging examination, all do alpha-fetoprotein determination, are diagnosed as primary hepatocarcinoma.Wherein, male's 25 examples, women's 25 examples, age 33-71 year, average 50.1 years old, wherein, II phase patient 20 examples, III phase patient 30 examples.
Receive people's standard
(1) with reference to the primary hepatocarcinoma diagnostic criteria of hepatocarcinoma Professional Committee of Chinese Anti-Cancer Association; (2) Chinese medical discrimination belong to syndrome of blood stasis (Ministry of Health of the People's Republic of China. new Chinese medicine clinical research guideline [S]. the 1st volume, 1993.170-731); (3) physical situation Karnofsky scoring is more than 60 minutes.
Take the decoction of preparation among the embodiment 1, three times on the one, each 50 milliliters.Treatment is 3 months continuously.
The therapeutic evaluation standard
The objective therapeutic evaluation standard of formulating according to WHO of solid tumor (the Sun Yan chief editor. medical oncology. Beijing: the People's Health Publisher, 2001.994-996) formulate following evaluation criteria: produce effects: treatment rear section transference cure, the Karnofsky integration reduces >=2/3; Effectively: treatment back symptom takes a turn for the better, and the Karnofsky integration reduces >=1/3, but<2/3; Invalid: treatment back symptom does not have obvious improvement, the constant or integration reduction<1/3 of Karnofsky integration.Karnofsky scoring: according to " situation score standard in the body " (the Sun Yan chief editor. medical oncology. Beijing: the People's Health Publisher, 2001.994-996) add up.
On inspection, whole 50 routine patients all meet the standard of produce effects after treating after treatment.
Untoward reaction: untoward reaction does not appear in 50 routine patients in therapeutic process.

Claims (2)

1. plant the medicament of treatment tumor, it is characterized in that it is processed by following bulk drugs by weight:
2. the medicament of treatment tumor according to claim 1 is characterized in that, said medicament is tablet, decoction or capsule.
CN2011102519461A 2011-08-30 2011-08-30 Medicament for treating tumor Expired - Fee Related CN102302719B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011102519461A CN102302719B (en) 2011-08-30 2011-08-30 Medicament for treating tumor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011102519461A CN102302719B (en) 2011-08-30 2011-08-30 Medicament for treating tumor

Publications (2)

Publication Number Publication Date
CN102302719A CN102302719A (en) 2012-01-04
CN102302719B true CN102302719B (en) 2012-11-28

Family

ID=45376701

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011102519461A Expired - Fee Related CN102302719B (en) 2011-08-30 2011-08-30 Medicament for treating tumor

Country Status (1)

Country Link
CN (1) CN102302719B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103919854B (en) * 2014-04-18 2017-05-03 温先敏 Application of butterflybush flower and extract thereof to preparation of medicament
CN106389546A (en) * 2016-10-18 2017-02-15 漯河医学高等专科学校 Traditional Chinese medicine for postoperative treatment of colorectal cancer and preparation method of traditional Chinese medicine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1437977A (en) * 2003-01-13 2003-08-27 许新琳 Medicine for treating lung cancer

Also Published As

Publication number Publication date
CN102302719A (en) 2012-01-04

Similar Documents

Publication Publication Date Title
CN103041312B (en) Traditional Chinese medicine composition with antineoplastic effect and preparation method and application thereof
CN101239112B (en) Chinese medicinal composition for regulating blood fat and preparation thereof
CN101234164B (en) Pharmaceutical combination for improving skin oil-water balance and acne symptom and preparation thereof
CN102008650A (en) Compound traditional Chinese medicine preparation for treating tumors and preparation method thereof
CN102302719B (en) Medicament for treating tumor
CN101804189B (en) Drug for treating primary dysmenorrhea
CN102309708B (en) Drug for treating tumor
CN104888137B (en) A kind of pharmaceutical preparation for treating polycystic ovary syndrome
CN101991807A (en) Chinese herbal compound for treating liver cancer
CN103705846A (en) Traditional Chinese medicine preparation for treating ovarian cyst
CN106309749A (en) Traditional Chinese medicine for treating cervical cancer
CN101623455B (en) Medicine for treating prostate hyperplasia
CN101411770B (en) Medicament for treating blood stasis accumulation type multiple sclerosis symptoms
CN103638149B (en) Traditional Chinese medicine composition for treating rectal cancer
CN104888149A (en) Drug for treating cervical cancer and preparation method for drug
CN102293916B (en) Medicine for treating orthodontic gingivitis
CN102225155B (en) Medicament composition for treating pulmonary fibrosis
CN103610932A (en) Medicament for treating urinary calculus
CN101664533A (en) Chinese medicament for treating acute and chronic mammary hyperplasia and preparation method
CN104352669B (en) A kind of application of Chinese medicine in weak sperm disease is treated
CN101411810B (en) Medicament for treating multiple sclerosis symptoms
CN103223149A (en) Chinese herb medicine composition for treating lung cancer
CN102836315A (en) Chinese medicinal composition for preventing and conditioning prognosis tumors and preparation method thereof
CN102526385A (en) Medicament for treating climacteric syndrome
CN102225154B (en) Medicament composition for treating pulmonary fibrosis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20121128

Termination date: 20130830